Director, Global Medical Excellence

Not Interested
Bookmark
Report This Job

profile Job Location:

Basel - Switzerland

profile Monthly Salary: Not Disclosed
Posted on: 9 hours ago
Vacancies: 1 Vacancy

Job Summary

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The companys R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The companys RAS(ON) inhibitors daraxonrasib (RMC-6236) a RAS(ON) multi-selective inhibitor; elironrasib (RMC-6291) a RAS(ON) G12C-selective inhibitor; zoldonrasib (RMC-9805) a RAS(ON) G12D-selective inhibitor; and RMC-5127 a RAS(ON) G12V-selective inhibitor are currently in clinical development. As a new member of the Revolution Medicines team you will join other outstanding professionals in a tireless commitment to patients with cancers harboring mutations in the RAS signaling pathway.

The Opportunity:

Revolution Medicines is seeking a Director Global Medical Excellence supporting the European region to serve as a key scientific and strategic partner to the Head of Global Medical Excellence. This role will help integrate and advance Medical Excellence initiatives across the portfolio for the European region by connecting science strategy and execution across the European regional Medical Affairs teams in collaboration with the global teams.

Key Responsibilities

  • Serve as a scientific thought partner to the Head of Global Medical Excellence helping translate medical strategy into aligned Medical Excellence priorities.

  • Connect and integrate scientific themes data narratives and strategic objectives across Medical Excellence functions (e.g. publications content & training stakeholder engagement analytics).

  • Support consistency and quality of scientific messaging and execution across global and regional Medical Affairs activities.

GlobalRegional Medical Partnership

  • Act as a key liaison between Global Medical Excellence and regional/local European Medical Affairs teams.

  • Facilitate bidirectional communication to ensure regional perspectives needs and insights inform global and European-specific Medical Excellence initiatives.

  • Support alignment of global frameworks with European regional execution realities particularly around congresses scientific exchange and launch readiness.

Medical Excellence Leadership Support

  • Support agenda setting scientific framing and follow-up for Medical Excellence leadership forums and key cross-functional discussions.

  • Help identify priorities risks and opportunities across Medical Excellence initiatives and proactively surface insights to leadership.

  • Prepare scientific briefings strategic summaries and leadership materials that enable effective decision-making.

Scientific Quality Governance & Continuous Improvement

  • Partner with Medical Governance to support scientific rigor compliance and quality standards across Medical Excellence activities.

  • Contribute to evolution of Medical Excellence ways of working ensuring they remain science-driven fit-for-purpose and scalable.

  • Identify opportunities to enhance integration reduce silos and strengthen scientific impact across Medical Affairs capabilities.

Digital & Systems Projects:

  • Support digital transformation initiatives within Medical Affairs including the implementation and optimization of medical systems databases and reporting tools.

  • Identify and deploy technology solutions that enhance efficiency data management and cross-functional collaboration.

  • Ensure seamless integration of digital tools to support Medical Affairs functions including grants management medical communications and insights tracking.

Cross-Functional Collaboration

  • Collaborate closely with Global Medical Strategy Medical Communications/Publications Medical Information Analytics & Insights Stakeholder Engagement and European Regional Medical Affairs.

  • Engage with Clinical Development HEOR Patient Advocacy and Commercial (as appropriate) to ensure aligned scientific narratives coordinated operations and compliant collaboration.

  • Serve as a connector across teams fostering a culture of Exceptional Together within Medical Affairs.

Required Skills Experience and Education:

  • Advanced degree in life sciences (PhD PharmD MD or equivalent preferred).

  • 10 years of experience in Medical Affairs Medical Strategy or a related global medical role.

  • Strong scientific acumen with the ability to synthesize complex data and communicate clearly to diverse audiences.

  • Experience working in globalregional Medical Affairs models.

  • Demonstrated ability to influence without authority and operate effectively in matrixed environments.

  • Excellent written and verbal communication skills with comfort supporting senior leadership.

Revolution Medicines takes protection and security of personal data very seriously and respects your right to privacy while using our website and when contacting us by email or phone. We will only collect process and use any personal data that you provide to us in accordance with ourCCPA additional information please contact.

#LI-Hybrid #LI-LO1

We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms email phone or text message.

Please note that Revolution Medicines does not extend unsolicited employment offers and will never ask candidates to provide financial information purchase equipment or pay fees as part of the hiring process. All legitimate communication from Revolution Medicines will come from an official @ email address.

If you believe youve been contacted by someone impersonating a Revolution Medicines recruiter please report it to so we can share these impersonations with our IT team for tracking and awareness.


Required Experience:

Director

Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The companys R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The companys RAS(ON) inhibitors daraxonra...
View more view more

About Company

We are aware of recent recruitment scams in which individuals or organizations falsely represent themselves as being affiliated with Revolution Medicines. These scams may appear as false job advertisements or unsolicited contacts through communication or chat platforms, email, phone, ... View more

View Profile View Profile